Resolution of conjunctival sessile hemangioma with topical timolol
- PMID: 24270678
- PMCID: PMC3895456
- DOI: 10.1097/ICO.0000000000000022
Resolution of conjunctival sessile hemangioma with topical timolol
Abstract
Purpose: To report a single case of acquired sessile hemangioma of the conjunctiva which resolved after treatment with topical timolol.
Methods: Case report and literature review.
Results: A 77-year-old African American woman developed an acquired sessile hemangioma of the conjunctiva of the right eye. She was followed for primary open-angle glaucoma, and the lesion was monitored for 12 months without change. Topical timolol-dorzolamide was then added to her glaucoma medication regimen twice daily. On follow-up examination 6 months later, the lesion had completely resolved.
Conclusions: In this case report, an acquired sessile hemangioma of the conjunctiva resolved with topical timolol therapy.
Figures
References
-
- Shields JA, Kligman BE, Mashayekhi A, et al. Acquired sessile hemangioma of the conjunctiva: a report of 10 cases. Am J Ophthalmol. 2011;152:55–59. - PubMed
-
- Shields JA, Mashayekhi A, Kligman BE, et al. Vascular tumors of the conjunctiva in 140 cases. Ophthalmology. 2011;118:1747–53. - PubMed
-
- Guo S, Ni N. Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution. Arch Ophthalmol. 2010;128:255–6. - PubMed
-
- Chakkittakandiyil A, Phillips R, Frieden IJ, et al. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study. Pediatr Dermatol. 2012;29:28–31. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical